Chargement en cours...
Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017
BACKGROUND: Direct oral anticoagulants (DOACs), namely rivaroxaban, apixaban, dabigatran, and edoxaban, are now included together with warfarin as standards of care for the primary treatment of venous thromboembolism (VTE). The extent to which the DOACs have been adopted since receiving US Food and...
Enregistré dans:
| Publié dans: | Res Pract Thromb Haemost |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6782014/ https://ncbi.nlm.nih.gov/pubmed/31624786 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12222 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|